Reglitazar

Reglitazar Uses, Dosage, Side Effects, Food Interaction and all others data.

Reglitazar, an isoxazolidine-3,5-dione derivative, is being developed by Pfizer for the treatment of diabetes. It is the first non-thiazolidenedione to enter clinical trials.

Reglixane shows a hypoglycemic effect and also a stronger triglyceride-lowering effect than the thiazolidine-2,4-diones. In preclinical studies, reglixane has been shown to prevent several diabetic complications, such as cataract, nephropathy, and neuropathy.

Trade Name Reglitazar
Generic Reglitazar
Reglitazar Other Names Reglitazar, Reglixane
Type
Formula C22H20N2O5
Weight Average: 392.411
Monoisotopic: 392.137221752
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Reglitazar
Reglitazar

Uses

For the treatment of diabetes mellitus type 1 and 2.

How Reglitazar works

Reglixane is an agonist of peroxisome proliferator-activated receptor (PPAR) gamma and alpha.

Innovators Monograph

You find simplified version here Reglitazar

*** Taking medicines without doctor's advice can cause long-term problems.
Share